OMTHERA PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors of Claims of Breaches of Fiduciary Duty by Board of Omthera Pharmaceuticals, Inc. in Connection With Sale of Company -- OMTH


NEW YORK, June 4, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors of Omthera Pharmaceuticals, Inc. ("Omthera" or the "Company") (Nasdaq:OMTH) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to AstraZeneca Plc (NYSE:AZN). A complaint was filed in Delaware state court.

Click here to learn more about the investigation http://zlk.9nl.com/omthera-pharamaceuticals-omth/, or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, Omthera shareholders will receive $12.70 for each share of Omthera stock they own. In addition, Omthera shareholders will receive approximately $4.70 in contingent value rights if certain benchmarks are met. Including the contingent rights, the transaction has a total approximate value of $443 million. The claims concern whether the Omthera Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the transaction, whether AstraZeneca is underpaying for Omthera stock, thus unlawfully harming Omthera shareholders.

If you own common stock in Omthera and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/omthera-pharamaceuticals-omth/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.



            

Contact Data